Cathy Skala

Cathy Skala is the CEO of CureX, board director, investor and a trusted advisor across the medical device and health tech sectors. She has over 25 years of executive and board leadership experience. Her collaborative approach drove growth through several challenging global transformations, including M&A, portfolio divestitures, activist pressure and digital technology redesigns. Her career in the healthcare industry included executive roles at Baxter (NYSE: BAX), Hospira (NYSE: HSP), currently Pfizer (NYSE: PFE) and Abbott (NYSE: ABT). Cathy leveraged her 10 years of software industry experience, serving as a CIO and overseeing emerging technology implementations, including AI, advanced analytics and master data, addressing fiduciary and risk perspectives.